Your institution may have access to this item. Find your institution then sign in to continue.
Title
Irresistible force meets immoveable object.
Abstract
The author reflects on the implementation of device regulation on direct-to-consumer (DTC) services by the U.S. Food and Drug Administration (FDA) which offer to interpret genome variation. Topics discussed include the 23andMe genome scan, premarket approval (PMA), and the true scope of human genetic variation.